ClinicalTrials.gg
RecruitingNCT06664229Updated Mar 20, 2026

Development of Pressure Sensor Based Dementia and Fall Prevention Program for Older Adults

An interventional study of Fall and dementia prevention exercise in Dementia, Mild, Accidental Falls and Mild Cognitive Impairment, sponsored by Sunmi Song. Recruiting at 1 site in South Korea. Open to participants aged 65 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-03-20.

Sponsored by Sunmi Song · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Started Jan 2024; still recruiting 2 years 10 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
205
Allocation
Randomized
Ages
65 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 52 studies in Dementia with a site in Korea, Republic of — 15 open to participants now, 18 under way, 4 of them phase 3. Dementia · Korea, Republic of.

Planned enrollment
23rd of 43
205 · median 220
Started
2024
with 5 others
No phase
13 of 52
5 open now
Primary completion
2026-12
later than 4 of 17 live
Registered
39th of 52
by date

Among the 52 studies in Dementia with a site in Korea, Republic of, this one is the 23rd largest by planned enrollment of the 43 interventional ones that give a count, is one of 6 that started in 2024, is one of 13 with no phase, reaches primary completion later than 4 of the 17 other live ones, and was the 39th registered.

Dementia

2,377 studies on the registry are indexed under Dementia; 572 are open to participants now.

Browse Dementia studies →

Open to participants now

15 of the 52 studies in Dementia with a site in Korea, Republic of are open now. Recruiting first, the newest first:

9 more — sign in →

All 15 open studies →

A study can be open while its sites in Korea, Republic of have not opened yet or have stopped. Only those recruiting at a site in Korea, Republic of →

Who these studies take

Of the 382 Dementia studies recruiting now, 242 (63%) set no upper age limit and 25 (7%) stop at 75 or younger; 15 take children under 18; 163 take healthy volunteers.

This study: 65 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 52 studies in Dementia with a site in Korea, Republic of, or all of them as a file.
02

Study summary

The goal of this intervention program is to test the effectiveness of pressure sensor based dementia and fall prevention program for improving cognitive and physical functions of community dwelling older adults. The main purposes of this study are:

  1. Develop a pressure sensor based exercise mat and linked software programs to be used for group training sessions for cognitive and balance training of older adults at a community senior center.
  2. Evaluate efficacy of the program to improve cognitive and physical functions of older adults via a pilot study and a main study with randomized control trial design.

Older adults will be asked to participate in a group training session that was lead by a fitness coach using a pressure sensor mat, a standing monitor, and a linked software programs. They will be asked to stand on the mat, which is set in front of a monitor to show positions of the mat where they place their foots. The monitor screen will guide them to conduct either a balancing exercise for fall prevention or a cognitive exercise such as memory game or quiz game for dementia prevention.

Researchers will compare age and gender matched control group in a main study to see if cognitive and balancing functions of intervention group is better than the control group by conducting pre and post surveys and physical examinations. A pilot study will examine pre-post changes in the intervention group without the control group.

Read the detailed description

A. Developed group exercise devices

○ The study will test the flexible, stretchable film-type pressure sensor embedded balance mat and a monitor that will present a sequence of fitness programs and cognitive tasks.

  • A 65cm wide balance mat embedded with pressure sensors will be utilized for balance trainings and responding to cognitive tasks.
  • The devices are consisted of hardware and software based on a thin, flexible pressure sensor (includes additional safety aids such as safety bars and surrounding cushion mats).
  • The thin pressure sensor allows for a lightweight, portable mat.

B. Pilot Test

  • The pilot test will be conducted with a single intervention group who participated in the group exercises using the developed devices that are led by a trainer.
  • Pre- and post-assessment: Two measurements will be taken before and after the intervention, evaluating balance, physical fitness, cognition, and quality of life.
  • User-centered interviews: One interview will be conducted after the intervention to gather participants' opinions on the exercise program and to determine the direction of future studies. The interview will use the Metaplan method, which was verified as an effective approach for developing assistive systems for older users in a previous study (Thoma-Lürken et al., 2018). The interview will be conducted with four participants from the pilot test, and the interview session will last 60 to 90 minutes, considering participants' needs for breaks. For effective data collection and analysis, the entire interview process will be recorded with participants' prior consent.

C. The main test

  • The main test will be conducted with single-blind, randomized controlled trial (RCT) design. The intervention group will participate in the group exercises using the developed devices that are led by a trainer.

    • Random assignment: Block randomization (block size 4) will be applied to randomly assign participants to the intervention group or the control group.
    • Single-blind (blinding of the evaluator): The evaluator will not be informed of the participants' group allocation during assessments.
  • Pre-, mid-, and post-assessment: Measurements will be taken three times-before the intervention, after 8 weeks of exercise, and after 16 weeks of exercise-assessing balance, physical fitness, cognition, depression, sleep, and quality of life.
03

Conditions studied

  • Dementia, Mild
  • Accidental Falls
  • Mild Cognitive Impairment

Keywords

  • Fall prevention
  • Dementia prevention
  • Mild cognitive impairment
  • Exercise game
  • Cognitive training game
  • Community based intervention
  • Older adults
04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Older adults in the community who are 65 years old or older.

Exclusion criteria

Exclusion Criteria:

  • Older adults who cannot walk independently with assisting devices or use wheelchair.
  • Older adults who are diagnosed with dementia, or other neurological/mental disorders that may limit their cognitive ability to participate in the study.
  • Older adults who cannot speak or read Korean.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
205 participants (estimated)

Study arms

  • Experimental
    Intervention group

    Older adults who participated in a group exercise program using the developed mat and software three times per week for six weeks (18 sessions) for a pilot study and twelve weeks (36 sessions) for a main study took part in the pre-post tests. The frequency and duration can be adjusted to twice per week for nine weeks (18 sessions) for a pilot study or twice per week for sixteen weeks (32 sessions) for a main study to accommodate the availability of participants and the spaces in the community center.

    Behavioral: Fall and dementia prevention exercise

  • No intervention
    Control group

    Older adults who participated only in the pre-post tests without receiving any intervention.

Interventions

  • BehavioralFall and dementia prevention exercise

    The fall and dementia prevention exercise is designed as a combination of balancing and cognitive exercise and games that is conducted as a group activity. The session will be provided three times per week for six weeks for a pilot test and three times per week for 12 weeks for a main comparison study. The fall prevention exercise involves the pressure mat based balancing exercise such as side stepping, heel or toe standing, and quarter squat. The safety bar will be placed around the mat, so that older adults with instability can hold while they follow the movements. The cognitive exercise will concise of multiple types of cognitive tasks to train memory, numeric processing, spatial perception, and logical thinking. For example, memory task such as memorizing the series of positions on the screen and use the mat to point the positions in the right order. At the end, older adults play games in which they use balancing movements and cognitive tasks to gain scores for their team.

06

What researchers measure

Primary outcomes

  1. The Mini-Mental State Exam Korean Version (MMSE-K)

    The Mini-Mental State Exam Korean version (MMSE-K) ranges from 0-30 with higher score indicating better cognitive function.

    Time frame: The system usability test will be conducted at baseline and within one week following the last session of the intervention.

  2. The Berg Balance test

    The Berg Balance test (Lusardi, 2004) ranges from 0 to 56 with lower score indicating the more risk of losing one's balance.

    Time frame: The Berg balance test will be conducted at baseline (one week before the first session), mid-term survey (6th week of 12 week program or 8th week of 16 week program), and within one week following the last session of the intervention (13th or 17th week).

  3. Sarcopenia index

    Sarcopenia-related measures, including appendicular skeletal muscle mass (ASM), appendicular skeletal muscle mass index (ASMI), and handgrip strength, were assessed according to the Asian Working Group for Sarcopenia 2019 criteria

    Time frame: The test will be conducted at baseline, and at the mid-term assessment, and within one week following the last session of the intervention.

  4. The figure of 8 walk test

    The figure of 8 walk test measures the time (seconds) to walk a figure-of-eight around 2 cones placed 2.4 m apart twice. The smaller score indicates the better walking ability of a participant.

    Time frame: The figure of 8 walk test will be conducted at baseline, mid-term survey, and within one week following the last session of the intervention.

  5. The 3 m sit-walk and return test

    The 3 m sit-walk and return test measures the time (seconds) from sitting on a chair to standing, walking to a 3 m target, and then returning to the chair and sitting down. The shorter test score indicates better fitness of a participant.

    Time frame: The 3 m sit-walk and return test will be conducted at baseline, mid-term survey, and within one week following the last session of the intervention.

  6. The 30 second sit-stand test

    The 30 second sit-stand test measures the number of completed chair stands in 30 seconds. The larger number of completed chair stands, the better physical fitness of a participant.

    Time frame: The 30 second sit-stand test will be conducted at baseline, mid-term survey, and within one week following the last session of the intervention.

  7. Montreal Cognitive Assessment (MoCA)

    MoCA test will be conducted to examine changes in cognitive functioning before and after the intervention program in addition to MMSE.

    Time frame: MoCA will be conducted at baseline and within one week following the last session of the intervention.

  8. The 2 minute step in place test

    The 2 minute step in place test (number): A test that measures the total number of times the right knee reaches the tape level in two minutes. The more number of reaches, the better fitness scores the participant has.

    Time frame: The 2 minute step in place test will be conducted at baseline, mid-term survey, and within one week following the last session of the intervention.

  9. The sit and reach test (cm)

    The sit and reach test (cm) measures the distance reached by the hand. The participant sits on the floor with legs stretched out straight ahead, with the soles of the feet flat against the box. Both knees should be locked and pressed flat to the floor. Reach forward with a slow and steady movement as far as possible, and hold that position for three seconds while the distance is recorded. The larger scores indicate the better fitness of the participant.

    Time frame: The sit and reach test will be conducted at baseline, mid-term survey, and within one week following the last session of the intervention.

Secondary outcomes

  1. Geriatic depression

    Geriatric depression scale score ranges from 0-15 with higher scores indicating more severe depressive symptoms.

    Time frame: Geriatric depression scale will be conducted at baseline and within one week following the last session of the intervention.

  2. Pain related functional limitations

    The brief version of the Western Ontario and McMaster Universities Osteoarthritis Index, which measures five items for pain (score range 0-20), two for stiffness (score range 0-8), and 17 for functional limitation (score range 0-68), with higher scores indicating worse pain and functional limitations in one's daily living.

    Time frame: The WOMAC will be conducted at baseline and within one week following the last session of the intervention.

  3. The Pittsburgh Sleep Quality Index (PSQI)

    The brief version of the Pittsburgh Sleep Quality Index ranges from 0 to 15 with higher score indicating more sleep problems.

    Time frame: The PSQI will be conducted at baseline, mid-term survey, and within one week following the last session of the intervention.

  4. The Morse Fall Risk Scale

    The Morse Fall Risk Scale ranges 0-125 with higher score indicating higher risk of fall.

    Time frame: The system usability test will be conducted at baseline and within one week following the last session of the intervention.

  5. WHO quality of life bref

    WHO quality of life bref assesses physical, psychological, social, environmental health, which ranges 7-35, 6-30, 3-15, 8-40, respectively, higher score indicating better physical, psychological, social, environmental health status.

    Time frame: The system usability test will be conducted at baseline and within one week following the last session of the intervention.

Other outcomes

  1. System Usability Test

    System usability test will be conducted to examine changes in the levels of usability for the digital devices that were developed for the intervention program.

    Time frame: The system usability test will be conducted at baseline, mid-term survey, and within one week following the last session of the intervention.

07

Study locations

1 of 1 sites recruiting
  • Korea University
    Seoul, Seoul 02841, South Korea
    Recruiting
    • Sunmi Song, PhD · Contactsunmi.song0715@gmail.com · +821087489593
    • Junesun Kim, PT/PhD · Principal investigator
    • Seyun Jang, BS · Sub investigator
    • Suk-chan Halm, PT/PhD · Sub investigator
    • Sunmi Song, PhD · Sub investigator
08

References and documents

Publications

  • Song S, Hahm SC, Chang S, Lee J, Kang H, Lee SH, Kim J. Feasibility and Preliminary Effects of a Pressure Sensor-Based Exergame on Cognitive and Sensorimotor Frailty in Low-Income Older Adults Receiving Public Community Care Services: Pilot Randomized Controlled Trial. JMIR Aging. 2026 Jul 24;9:e93467. doi: 10.2196/93467. PubMed 42497405 ↗

Individual participant data

Plan to share: No — The IRB approval of this study do not allow sharing data from this study with other researchers.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2024 (actual). Primary completion is estimated for Dec 2026, 35 months after the start.

Of 862 non-industry interventional studies with no phase under Dementia, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 44. This study's planned 35 months is above that.

Counting every sponsor, half of 908 studies reached it within 25 months; a quarter within 11 and three quarters within 43.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 28, 2024
First posted
Oct 29, 2024
StartActual
Jan 15, 2024
Primary completionEst.
Dec 31, 2026
CompletionEst.
Dec 31, 2026
Last update
Mar 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 20, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06664229
Lead sponsor
Sunmi Song
Responsible party
Sunmi Song (Research Professor, Korea University) — Sponsor-investigator
First posted
Oct 29, 2024
Start date
Jan 15, 2024
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Mar 20, 2026

Study contacts

Sunmi Song, PhD
Contact
sunmi.song0715@gmail.com
821087489593
Junesun Kim, PT/PhD
principal investigator · Korea University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion